These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 33583075)
21. Fragment library design, synthesis and expansion: nurturing a synthesis and training platform. Ray PC; Kiczun M; Huggett M; Lim A; Prati F; Gilbert IH; Wyatt PG Drug Discov Today; 2017 Jan; 22(1):43-56. PubMed ID: 27793744 [TBL] [Abstract][Full Text] [Related]
22. Bionoi: A Voronoi Diagram-Based Representation of Ligand-Binding Sites in Proteins for Machine Learning Applications. Feinstein J; Shi W; Ramanujam J; Brylinski M Methods Mol Biol; 2021; 2266():299-312. PubMed ID: 33759134 [TBL] [Abstract][Full Text] [Related]
23. On the origins of three-dimensionality in drug-like molecules. Meyers J; Carter M; Mok NY; Brown N Future Med Chem; 2016 Sep; 8(14):1753-67. PubMed ID: 27572621 [TBL] [Abstract][Full Text] [Related]
24. 970 million druglike small molecules for virtual screening in the chemical universe database GDB-13. Blum LC; Reymond JL J Am Chem Soc; 2009 Jul; 131(25):8732-3. PubMed ID: 19505099 [TBL] [Abstract][Full Text] [Related]
25. V-Dock: Fast Generation of Novel Drug-like Molecules Using Machine-Learning-Based Docking Score and Molecular Optimization. Choi J; Lee J Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769065 [TBL] [Abstract][Full Text] [Related]
26. Development and Validation of Molecular Overlays Derived from Three-Dimensional Hydrophobic Similarity with PharmScreen. Vázquez J; Deplano A; Herrero A; Ginex T; Gibert E; Rabal O; Oyarzabal J; Herrero E; Luque FJ J Chem Inf Model; 2018 Aug; 58(8):1596-1609. PubMed ID: 30010337 [TBL] [Abstract][Full Text] [Related]
28. Automated Generation of Novel Fragments Using Screening Data, a Dual SMILES Autoencoder, Transfer Learning and Syntax Correction. Bilsland AE; McAulay K; West R; Pugliese A; Bower J J Chem Inf Model; 2021 Jun; 61(6):2547-2559. PubMed ID: 34029470 [TBL] [Abstract][Full Text] [Related]
29. Performance of Deep and Shallow Neural Networks, the Universal Approximation Theorem, Activity Cliffs, and QSAR. Winkler DA; Le TC Mol Inform; 2017 Jan; 36(1-2):. PubMed ID: 27783464 [TBL] [Abstract][Full Text] [Related]
30. From Target to Drug: Generative Modeling for the Multimodal Structure-Based Ligand Design. Skalic M; Sabbadin D; Sattarov B; Sciabola S; De Fabritiis G Mol Pharm; 2019 Oct; 16(10):4282-4291. PubMed ID: 31437001 [TBL] [Abstract][Full Text] [Related]
33. De Novo Molecule Design by Translating from Reduced Graphs to SMILES. Pogány P; Arad N; Genway S; Pickett SD J Chem Inf Model; 2019 Mar; 59(3):1136-1146. PubMed ID: 30525594 [TBL] [Abstract][Full Text] [Related]
34. Complex machine learning model needs complex testing: Examining predictability of molecular binding affinity by a graph neural network. Nikolaienko T; Gurbych O; Druchok M J Comput Chem; 2022 Apr; 43(10):728-739. PubMed ID: 35201629 [TBL] [Abstract][Full Text] [Related]
35. A Drug Decision Support System for Developing a Successful Drug Candidate Using Machine Learning Techniques. Onay A; Onay M Curr Comput Aided Drug Des; 2020; 16(4):407-419. PubMed ID: 31438830 [TBL] [Abstract][Full Text] [Related]
37. Graph-based generative models for de Novo drug design. Xia X; Hu J; Wang Y; Zhang L; Liu Z Drug Discov Today Technol; 2019 Dec; 32-33():45-53. PubMed ID: 33386094 [TBL] [Abstract][Full Text] [Related]